Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene
- 1 July 1995
- journal article
- review article
- Published by Elsevier in Chemosphere
- Vol. 31 (1), 2561-2578
- https://doi.org/10.1016/0045-6535(95)00124-q
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Negative selection in hepatic tumor promotion in relation to cancer risk assessmentToxicology, 1995
- Use of Mechanistic Models to Estimate Low‐Dose Cancer RisksRisk Analysis, 1994
- The role of dichloroacetate in the hepatocarcinogenicity of trichloroethyleneToxicology Letters, 1993
- Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: implications for the risk of trichloroethene exposure.Environmental Health Perspectives, 1993
- Evaluating the Risk of Liver Cancer in Humans Exposed to Trichloroethylene Using Physiological ModelsRisk Analysis, 1993
- A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethyleneChemico-Biological Interactions, 1992
- Consideration of the Target Organ Toxicity of Trichloroethylene in Terms of Metabolite Toxicity and PharmacokineticsDrug Metabolism Reviews, 1991
- IARC carcinogenicity evaluations of vinylidine chloride, methylene dichloride and trichloroethyleneEnvironmental Research, 1989
- Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesisToxicology Letters, 1988
- Lifespan oral toxicity study of vinyl chloride in ratsFood and Cosmetics Toxicology, 1981